These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6579706)
21. Platelet survival and function in animals with prosthetic mitral valve: the effect of nafazatrom. Al-Mondhiry H; Pierce WS; Richenbacher W Thromb Haemost; 1984 Oct; 52(2):99-101. PubMed ID: 6523440 [TBL] [Abstract][Full Text] [Related]
22. Reduction of myocardial infarction and dysrhythmic activity by nafazatrom in the conscious rat. Fiedler VB Eur J Pharmacol; 1983 Mar; 88(2-3):263-7. PubMed ID: 6852112 [TBL] [Abstract][Full Text] [Related]
23. Mechanism of action of nafazatrom. Seuter F; Busse WD Thromb Res Suppl; 1983; 4():75-80. PubMed ID: 6415860 [No Abstract] [Full Text] [Related]
24. First use of nafazatrom, a new antithrombotic drug, in pregnancy. Elder MG; Myatt L Lancet; 1984 Jun; 1(8390):1350. PubMed ID: 6145042 [No Abstract] [Full Text] [Related]
25. Manipulation of the local thromboxane and prostacyclin balance in vivo by the antithrombotic compounds dazoxiben, acetylsalicylic acid and nafazatrom. Deckmyn H; Van Houtte E; Verstraete M; Vermylen J Biochem Pharmacol; 1983 Sep; 32(18):2757-62. PubMed ID: 6578796 [TBL] [Abstract][Full Text] [Related]
26. High-performance liquid chromatographic determination of nafazatrom in human plasma using fluorescence detection. Evans LJ; Young JD; Hutchison JS; Baker LH J Chromatogr; 1984 Jan; 305(1):163-70. PubMed ID: 6707139 [TBL] [Abstract][Full Text] [Related]
27. Effect of nafazatrom on platelet function and release: relationship to symptomatic episodes in patients with peripheral vascular disease. Buchanan MR; Butt RW; Turpie AG Am Heart J; 1987 May; 113(5):1133-7. PubMed ID: 2953219 [TBL] [Abstract][Full Text] [Related]
29. Phase I and pharmacologic evaluation of nafazatrom in patients with cancer. Haas CD; Baker LH; Evans LJ Invest New Drugs; 1984; 2(1):13-7. PubMed ID: 6469495 [TBL] [Abstract][Full Text] [Related]
30. Interference with tumor cell-induced degradation of endothelial matrix on the antimetastatic action of nafazatrom. Maniglia CA; Loulakis PP; Sartorelli AC J Natl Cancer Inst; 1986 Apr; 76(4):739-44. PubMed ID: 3457206 [TBL] [Abstract][Full Text] [Related]
32. Nafazatrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function. Bednar M; Smith B; Pinto A; Mullane KM Circ Res; 1985 Jul; 57(1):131-41. PubMed ID: 2988818 [TBL] [Abstract][Full Text] [Related]
33. The beneficial effects of nafazatrom (BAYg6575) on experimental coronary thrombosis. Shea MJ; Driscoll EM; Romson JL; Pitt B; Lucchesi BR Am Heart J; 1984 Apr; 107(4):629-37. PubMed ID: 6702555 [TBL] [Abstract][Full Text] [Related]
34. The effects of oral nafazatrom (= BAY g 6575) on canine coronary artery thrombosis and myocardial ischemia. Fiedler VB Basic Res Cardiol; 1983; 78(3):266-80. PubMed ID: 6615399 [TBL] [Abstract][Full Text] [Related]
35. Platelet aggregation in arterioles of the hamster cheek pouch and in heart transplants: its tissue-dependent influencibility by acetylsalicylic acid and nafazatrom. Herrmann KS; Seuter F Haemostasis; 1984; 14(3):281-7. PubMed ID: 6381254 [TBL] [Abstract][Full Text] [Related]
36. Nafazatrom (Bay g 6575) inhibition of tumor cell lipoxygenase activity and cellular proliferation. Honn KV; Dunn JR FEBS Lett; 1982 Mar; 139(1):65-8. PubMed ID: 6804263 [No Abstract] [Full Text] [Related]
37. Clinical study of a new antimetastatic compound, Nafazatrom (Bay g 6575). Effects on platelet consumption and monocyte prostaglandin production in patients with advanced cancer. Warrell RP; Bockman RS; Staszewski H; Maiese K Cancer; 1986 Apr; 57(8):1455-60. PubMed ID: 2936443 [TBL] [Abstract][Full Text] [Related]
38. Nafazatrom inhibits peroxidation of phosphatidylcholine liposomes, heart homogenate and low density lipoproteins. Ondrias K; Stasko A; Gergèl D; Ondriasovà E; Hromadová M Gen Physiol Biophys; 1997 Jun; 16(2):151-62. PubMed ID: 9437256 [TBL] [Abstract][Full Text] [Related]
40. A clinical study of nafazatrom in advanced human breast cancer. Jones AL; Powles TJ; Forgeson GV; Coombes RC Cancer Chemother Pharmacol; 1991; 27(4):326-8. PubMed ID: 1998990 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]